Diabetes has developed into a major global problem.The disorder is affecting younger and younger people and complications related to diabetes are currently among the most common causes of death in many countries.In conjunction with the spin-out of the new Diamyd Medical from the Parent Company in April 2013, a dedicated diabetes company was formed.The company will now be listed on NASDAQ OMX First North and the first day of trading is May 20.
Stockholm - Tele2 AB (Tele2), (NASDAQ OMX Stockholm: TEL2 A and TEL2 B) today announced that the company's Annual General Meeting (AGM) held today voted to support all of the resolutions that the Board of Directors and Nomination Committee proposed to the AGM.
